Personalis, INC Form 4 insider transactions

Personalis, Inc.'s CFO and COO, Aaron Tachibana, exercised stock options and subsequently sold an equal number of common shares on January 22, 2026, under a pre-arranged 10b5-1 trading plan.

Personalis, Inc.'s CFO and COO, Aaron Tachibana, exercised stock options and subsequently sold 103,668 shares of common stock for a weighted average price of $10.78 per share.

Personalis, Inc. CEO Christopher M. Hall sold 29,612 shares of common stock at a weighted average price of $8.99 to cover tax withholding obligations from vested restricted stock units.

Personalis, Inc.'s Chief Medical Officer, Richard Chen, sold 452 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Personalis, Inc.'s CFO and COO, Aaron Tachibana, sold 641 shares of common stock at $6.57 per share to cover tax withholding obligations from vested restricted stock units.

Personalis CFO Aaron Tachibana sold 1,291 shares of common stock on May 16, 2025, to cover tax withholding obligations from vested restricted stock units.

Stephen Michael Moore, SVP and Chief Legal Officer of Personalis, Inc., sold 1,675 shares of common stock on May 16, 2025, to cover tax withholding obligations.

Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., sold 910 shares of common stock on May 16, 2025, to cover tax withholding obligations.

Olivia Kyusuk Bloom, a director at Personalis, Inc., was granted stock options to purchase 50,000 shares of common stock on May 16, 2025.

Director Lonnie Shoff acquired 50,000 stock options in Personalis, Inc. on May 16, 2025, according to a Form 4 filing with the SEC.

Director Kenneth J. Widder acquired 50,000 stock options in Personalis, Inc. on May 16, 2025, at an exercise price of $4.95.

Director Karin Eastham acquired 50,000 stock options in Personalis, Inc. on May 16, 2025, according to a Form 4 filing.

Director A. Blaine Bowman of Personalis, Inc. was granted stock options to purchase 50,000 shares of common stock at an exercise price of $4.95 on May 16, 2025.

Director Woodrow A. Myers Jr. of Personalis, Inc. acquired 50,000 stock options on May 16, 2025, exercisable at $4.95, according to a Form 4 filing.

Aaron Tachibana, CFO and COO of Personalis, Inc., acquired 250,000 stock options on March 15, 2025, according to a Form 4 filing with the SEC.

Stephen Michael Moore, SVP and Chief Legal Officer of Personalis, Inc., reports the acquisition of 225,000 stock options.

Personalis, Inc. CEO Christopher M Hall acquired 680,000 stock options on March 15, 2025, according to a Form 4 filing with the SEC.

Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., acquired 250,000 stock options on March 15, 2025, exercisable at $3.63.

Aaron Tachibana, CFO and COO of Personalis, Inc., sold 708 shares of common stock on January 28, 2025, to cover tax withholding obligations.

Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., sold 519 shares of common stock on January 28, 2025, to cover tax withholding obligations.

Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., sold 4,834 shares of common stock on December 16, 2024, to cover tax withholding obligations.

Stephen Michael Moore, SVP and Chief Legal Officer of Personalis, Inc., reports the sale of 1,513 shares of common stock on December 16, 2024.

Personalis CFO Aaron Tachibana sold 6,865 shares of common stock on December 16, 2024, to cover tax withholding obligations.

Personalis CFO and COO, Aaron Tachibana, sold 1,307 shares of common stock to cover tax obligations related to vested restricted stock units.

Stephen Michael Moore, SVP and Chief Legal Officer at Personalis, Inc., sold 1,693 shares of common stock to cover tax obligations from vested restricted stock units.

Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., sold 921 shares of common stock to cover tax obligations from vested restricted stock units.

Personalis, Inc. CEO Christopher M. Hall sold 26,443 shares of common stock on November 1, 2024, to cover tax withholding obligations.

Tempus AI, a 10% owner of Personalis, Inc., reports acquiring and disposing of common stock and warrants in Personalis on August 16, 2024.

Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., sold 524 shares of common stock on July 30, 2024, to cover tax withholding obligations.

Personalis CFO Aaron Tachibana sold 742 shares of common stock on July 30, 2024, to cover tax withholding obligations from vested restricted stock units.